OA20.01 Tumor Mutation Burden (TMB) is Associated with Improved Efficacy of Atezolizumab in 1L and 2L+ NSCLC Patients
Marcin Kowanetz, Wei Zou, David S. Shames et al. · Journal of Thoracic Oncology · 2017
Cited by 86 works. doi:10.1016/j.jtho.2016.11.343 Open-access PDF
Authors
- Marcin Kowanetz
- Wei Zou
- David S. Shames
- Craig A. Cummings
- Naiyer A. Rizvi
- Alexander I. Spira
- Garrett Michael Frampton
- Vincent Lévêque
- Susan Flynn
- Simonetta Mocci
- Geetha Shankar
- Roel Peter Funke
- Marcus D. Ballinger
- Daniel Waterkamp
- Daniel S. Chen
- Alan Sandler
- Garret M. Hampton
- Lukas C. Amler
- Priti S. Hegde
- Matthew David Hellmann